IPO Market — India IPO tracker

Mankind Pharma Limited IPO

LISTEDMAINBOARDMANKIND

Listing Performance

Listed

Issue Price

₹1,080

Listed On

09 May 2023

Price Band
₹1,080 – ₹1,080
Lot Size
TBA
Lot Value
TBA
Open Date
25 Apr 2023
Close Date
27 Apr 2023
Get GMP, subscription & allotment alerts for this IPO:Join Telegram

Mankind Pharma Limited — Live Stock Performance

IPO Timeline

Issue Opens

25 Apr 2023 · Tue

Issue Closes

27 Apr 2023 · Thu

Bidding Cut-off (UPI Mandate)

27 Apr 2023 · 5:00 PM IST

4

Allotment

TBA

Listing

09 May 2023 · Tue

✍️ Demand & Risk Analysis

Based on market demand signals — subscription, GMP trend, risk factors

IPO Market Analysis

ANALYSIS PENDING

Rating will be available once IPO opens for subscription.

This is algorithmic analysis, not investment advice. Always read the DRHP before investing.

IPO Details

Registrar
ExchangeNSE,BSE
ISIN
Face Value
Issue Size
Fresh Issue
OFS Size
Lead Managers

Company Fundamentals

Capital Structure

Capital structure not yet available.

Shareholding Pattern

Shareholding pattern not yet available.

Reservations & OFS

Reservation & OFS detail not yet available.

Board & Management

Board & management not yet available.

Industry & Market

Industry & market data not yet available.

3-Year Financial Summary

Financial data not available yet.

Subscription Status

Subscription data will appear once bidding begins.

Allotment Statistics

Basis of Allotment

Category-wise subscription & allotment ratio

View →

Recently Listed IPOs

CompanyListedListing Gain
Knack packaging08 Jul 2026
Aastha Spintex Limited06 Jul 2026
CSM Technologies Limited02 Jul 2026

Related IPOs

Documents

Documents not available yet

Frequently Asked Questions

When is the Mankind Pharma Limited IPO opening?

The Mankind Pharma Limited IPO opens on 25 Apr 2023 and closes on 27 Apr 2023. Check this page for the latest updates as we refresh every 30 minutes.

What is the price band of the Mankind Pharma Limited IPO?

The price band for the Mankind Pharma Limited IPO is ₹1,080 to ₹1,080. The final price is announced after the book-building process and is confirmed before listing.

What is the lot size and minimum investment for the Mankind Pharma Limited IPO?

The minimum lot size is TBA shares with a minimum investment of not yet announced. Retail investors can apply for up to the retail limit defined by SEBI.

What is the GMP of Mankind Pharma Limited IPO today?

Grey Market Premium data for Mankind Pharma Limited is not available yet. It typically starts appearing a few days before the IPO opens.

When will the Mankind Pharma Limited IPO list on NSE and BSE?

The Mankind Pharma Limited IPO is expected to list on 09 May 2023 on NSE,BSE. Actual listing day trading begins at the start of the normal market session.

How can I check the Mankind Pharma Limited IPO allotment status?

You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.

Is the Mankind Pharma Limited IPO a mainboard or SME issue?

Mankind Pharma Limited is a mainboard IPO that will list on the main NSE and BSE boards. Mainboard IPOs are open to retail investors with a minimum application of one lot.

How do I apply for the Mankind Pharma Limited IPO?

You can apply for the Mankind Pharma Limited IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA. Use the Apply Now buttons on this page to go directly to the broker.

Should I subscribe to Mankind Pharma Limited IPO?

Based on our algorithmic analysis, Mankind Pharma Limited IPO is rated UNRATED with low confidence. Rating will be available once subscription and GMP data is collected. This is not investment advice — please read the DRHP and consult a financial advisor before investing.

Related Articles

IPO Tools

Financial Disclaimer: The information on this page is for educational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Grey Market Premium (GMP) figures are unofficial and not endorsed by SEBI, NSE, or BSE. Past performance is not indicative of future returns. Please read the RHP and consult a SEBI-registered advisor before investing.